Clinical trial delays: what they mean and why you should careWhen it comes to clinical trials, time is money. And a delay in a trial can mean a drop in a drugs net value, lost ground to competitors, or an increased risk of failure or it can signal more bad news to come. But not all trial delays are red flags. How often is a pushed back timeline a bad omen? How often is it a minor inconvenience? And how can you predict the difference? Its not as easy as it sounds: It can be hard to get full information about